A total of 43 (11.0%) participants developed TB while receiving ART which was independently associated with male gender (OR = 2.9; p=0.007), WHO clinical stage 3 and 4 (OR = 1.4; p=0.029), baseline CD4 count <200 cells/μl (OR = 9.1; p < 0.001), and having not used IPT (OR = 3.1; p=0.05). Here, CD4 is linked to tuberculosis.